Open Access
Open access
том 20 издание 1 номер публикации 164

An esculentin-1 homolog from a dark-spotted frog (Pelophylax nigromaculatus) possesses antibacterial and immunoregulatory properties

Тип публикацииJournal Article
Дата публикации2024-04-27
SCImago Q1
WOS Q1
БС1
SJR0.697
CiteScore4.3
Impact factor2.6
ISSN17466148
Краткое описание
Background

Esculentin-1, initially discovered in the skin secretions of pool frogs (Pelophylax lessonae), has demonstrated broad-spectrum antimicrobial activity; however, its immunomodulatory properties have received little attention.

Results

In the present study, esculentin-1 cDNA was identified by analysing the skin transcriptome of the dark-spotted frog (Pelophylax nigromaculatus). Esculentin-1 from this species (esculentin-1PN) encompasses a signal peptide, an acidic spacer peptide, and a mature peptide. Sequence alignments with other amphibian esculentins-1 demonstrated conservation of the peptide, and phylogenetic tree analysis revealed its closest genetic affinity to esculentin-1P, derived from the Fukien gold-striped pond frog (Pelophylax fukienensis). Esculentin-1PN transcripts were observed in various tissues, with the skin exhibiting the highest mRNA levels. Synthetic esculentin-1PN demonstrated antibacterial activity against various pathogens, and esculentin-1PN exhibited bactericidal activity by disrupting cell membrane integrity and hydrolyzing genomic DNA. Esculentin-1PN did not stimulate chemotaxis in RAW264.7, a murine leukemic monocyte/macrophage cell line. However, it amplified the respiratory burst and augmented the pro-inflammatory cytokine gene (TNF-α and IL-1β) expression in RAW264.7 cells.

Conclusions

This novel finding highlights the immunomodulatory activity of esculentin-1PN on immune cells.

Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
BMC Veterinary Research
1 публикация, 33.33%
Molecules
1 публикация, 33.33%
Frontiers in Immunology
1 публикация, 33.33%
1

Издатели

1
Springer Nature
1 публикация, 33.33%
MDPI
1 публикация, 33.33%
Frontiers Media S.A.
1 публикация, 33.33%
1
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
3
Поделиться
Цитировать
ГОСТ |
Цитировать
Chen J. et al. An esculentin-1 homolog from a dark-spotted frog (Pelophylax nigromaculatus) possesses antibacterial and immunoregulatory properties // BMC Veterinary Research. 2024. Vol. 20. No. 1. 164
ГОСТ со всеми авторами (до 50) Скопировать
Chen J., Yu C., Zhou M., Zhang G., Su H., Ding G., Wei L., Lin Z., Ma L. An esculentin-1 homolog from a dark-spotted frog (Pelophylax nigromaculatus) possesses antibacterial and immunoregulatory properties // BMC Veterinary Research. 2024. Vol. 20. No. 1. 164
RIS |
Цитировать
TY - JOUR
DO - 10.1186/s12917-024-04013-y
UR - https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-024-04013-y
TI - An esculentin-1 homolog from a dark-spotted frog (Pelophylax nigromaculatus) possesses antibacterial and immunoregulatory properties
T2 - BMC Veterinary Research
AU - Chen, Jie
AU - Yu, Ci-Gang
AU - Zhou, Min-min
AU - Zhang, Gao-Jian
AU - Su, Hai-Long
AU - Ding, Guo-Hua
AU - Wei, Li
AU - Lin, Zhi-Hua
AU - Ma, Li
PY - 2024
DA - 2024/04/27
PB - Springer Nature
IS - 1
VL - 20
PMID - 38678277
SN - 1746-6148
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2024_Chen,
author = {Jie Chen and Ci-Gang Yu and Min-min Zhou and Gao-Jian Zhang and Hai-Long Su and Guo-Hua Ding and Li Wei and Zhi-Hua Lin and Li Ma},
title = {An esculentin-1 homolog from a dark-spotted frog (Pelophylax nigromaculatus) possesses antibacterial and immunoregulatory properties},
journal = {BMC Veterinary Research},
year = {2024},
volume = {20},
publisher = {Springer Nature},
month = {apr},
url = {https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-024-04013-y},
number = {1},
pages = {164},
doi = {10.1186/s12917-024-04013-y}
}
Ошибка в публикации?